Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.69 is 12% above its 5-year average of 1.51, near the high end of its 5-year range (0.90–1.83).
As of the fiscal period ended Saturday, June 27, 2026. 1.81% above its 12-month average of 1.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-27): 1.69.
CURRENT RATIO
1.69
CURRENT RATIO AVG TTM
1.66
CURRENT RATIO AVG 3Y
1.53
CURRENT RATIO AVG 5Y
1.51
CURRENT RATIO AVG 10Y
1.53
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.81%
CURRENT VS 3Y AVG
+10.65%
CURRENT VS 5Y AVG
+11.66%
CURRENT VS 10Y AVG
+10.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-52.35%
vs the sector median at left
Market Cap
$888.92M
Current Ratio
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$873.70M
Current Ratio
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
Market Cap
$872.19M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
Market Cap
$936.13M
Current Ratio
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$945.04M
Current Ratio
12.56
TTM Avg
15.19
3Y Avg
22.99
5Y Avg
17.56
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | $902.11M | 1.69 | 1.66 | 1.53 | 1.51 |
| Arbutus Biopharma Corp (ABUS)vs › | $888.92M | 81.42 | 11.94 | 8.59 | 10.34 |
| HealthStream, Inc. (HSTM)vs › | $917.04M | 1.06 | 1.14 | 1.09 | 1.06 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $873.70M | 16.16 | 3.88 | 3.97 | 4.50 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $872.19M | 1.95 | 2.27 | 2.05 | 2.13 |
| CeriBell, Inc. (CBLL)vs › | $934.93M | 9.18 | 13.23 | 9.24 | 9.24 |
| SI-BONE, Inc. (SIBN)vs › | $865.70M | 9.15 | 8.11 | 7.93 | 9.72 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $936.13M | 11.36 | 7.20 | 7.20 | 7.20 |
| MoonLake Immunotherapeutics (MLTX)vs › | $945.04M | 12.56 | 15.19 | 22.99 | 17.56 |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | 3.05 | 43.83 | 35.58 | 35.58 |
Current Ratio
1.69
Quick Ratio
1.17
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-27 | 1.69 |
| 2026-03-28 | 1.69 |
| 2025-12-31 | 1.70 |
| 2025-09-27 | 1.74 |
| 2025-06-28 | 1.48 |
| 2025-03-29 | 1.43 |
| 2024-12-31 | 1.31 |
| 2024-09-28 | 1.41 |
| 2024-06-29 | 1.33 |
| 2024-03-30 | 1.53 |
| 2023-12-31 | 1.53 |
| 2023-09-30 | 1.55 |
| 2023-07-01 | 1.46 |
| 2023-04-01 | 1.57 |
| 2022-12-31 | 0.90 |
| 2022-10-01 | 0.94 |
| 2022-07-02 | 1.39 |
| 2022-04-02 | 1.43 |
| 2021-12-31 | 1.45 |
| 2021-10-02 | 1.53 |
| 2021-07-03 | 1.83 |
| 2021-04-03 | 1.82 |
| 2020-12-31 | 1.73 |
| 2020-09-30 | 1.73 |
| 2020-06-30 | 2.41 |
| 2020-03-28 | 0.00 |
| 2019-12-06 | 2.06 |
| 2019-12-06 | 0.00 |
| 2019-06-29 | 0.00 |
| 2019-03-29 | 0.00 |
| 2016-03-31 | 1.15 |
| 2015-03-31 | 0.00 |
